CNTX earnings date and last-quarter result: last quarter miss, P/E -1.45. Updated 2026-07-23.
Context Therapeutics (CNTX) Research Hub
Context Therapeutics (CNTX) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 0.2399 USD (+0.25%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -1.45, market cap 0.06B. This hub links to the full technical, earnings and options research available for CNTX.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 0.2399 USD (+0.25%) |
| 52-week range | 0.2171 USD – 1.3 USD |
| Trend regime | Range |
| 14-day RSI | 18.2 (Oversold) |
| Trailing P/E | -1.45 |
| Market cap | 0.06B |
| Dividend yield | 0.00% |
Available research for CNTX
Covered Call on CNTX: how it works, illustrative setup around the real 0.2399 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on CNTX: how it works, illustrative setup around the real 0.2399 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on CNTX: how it works, illustrative setup around the real 0.2399 USD price, max profit/loss, breakeven and when to use it. Educational.
CNTX technical analysis: range, last 0.2399 USD, RSI 18.2, 52w range 0.2171 USD–1.3 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is CNTX in?
Context Therapeutics (CNTX) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is CNTX in an uptrend or downtrend?
As of 2026-10-26, CNTX is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is CNTX's trailing P/E ratio?
CNTX's trailing P/E is -1.45, with a market cap of 0.06B. See the earnings research page for full valuation detail.